Common Contracts
4 similar Employment Agreement contracts by Tracon Pharmaceuticals, Inc.
EMPLOYMENT AGREEMENT For MARK WIGGINSEmployment Agreement • February 25th, 2021 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • California
This Employment Agreement (the “Agreement”) is made and entered into effective as of January 27, 2021 (the “Effective Date”), by and between TRACON Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Mark Wiggins (the “Executive”). The Company and Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. From and following the Effective Date, this Agreement shall replace and supersede that certain Amended and Restated Employment Agreement between Executive and Company entered into as of May 28, 2018 (the “Prior Agreement”). Certain capitalized terms used in this Agreement are defined in Section 11.
EMPLOYMENT AGREEMENT For SCOTT BROWNEmployment Agreement • February 28th, 2020 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • California
This Employment Agreement (the “Agreement”) is made and entered into effective as of January 28, 2020 (the “Effective Date”), by and between TRACON Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Scott Brown (the “Executive”). The Company and Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”.
TRACON PHARMACEUTICALS, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 1st, 2017 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • California
This Amended and Restated Employment Agreement (the “Agreement”) is made and entered into effective as of February 27, 2017 (the “Effective Date”), by and between TRACON Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and H. Casey Logan (the “Executive”). The Company and Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. From and following the Effective Date, this Agreement along with the Severance Agreement entered into by and between Executive and the Company concurrently with this Agreement (the “Severance Agreement”) shall replace and supersede that certain Employment Agreement between Executive and Company entered into as of February 18, 2013 (the “Prior Agreement”). Certain capitalized terms used in this Agreement are defined in Section 11.
EMPLOYMENT AGREEMENT For PATRICIA BITAREmployment Agreement • March 1st, 2017 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • California
This Employment Agreement (the “Agreement”) is made and entered into effective as of February 27, 2017 (the “Effective Date”), by and between TRACON Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Patricia Bitar (the “Executive”). The Company and Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. From and following the Effective Date, this Agreement along with the Amended and Restated Severance Agreement entered into by and between Executive and the Company concurrently with this Agreement (the “Amended Severance Agreement”) shall set forth the terms of Executive’s employment and shall supersede the terms of the Severance Agreement between the Company and Executive dated February 15, 2016 (the “Prior Agreement”). Certain capitalized terms used in this Agreement are defined in Section 11.
